Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

REALMUTO, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.576
EU - Europa 2.577
AS - Asia 789
AF - Africa 43
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 12
Totale 8.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.546
IT - Italia 1.020
FI - Finlandia 531
CN - Cina 477
IE - Irlanda 225
UA - Ucraina 142
DE - Germania 135
GB - Regno Unito 115
SG - Singapore 104
BE - Belgio 77
RU - Federazione Russa 76
KR - Corea 65
FR - Francia 62
IR - Iran 52
SE - Svezia 37
RO - Romania 34
IN - India 30
PL - Polonia 29
CI - Costa d'Avorio 22
NL - Olanda 21
CA - Canada 20
ES - Italia 20
EG - Egitto 18
AU - Australia 15
CZ - Repubblica Ceca 15
TR - Turchia 14
HK - Hong Kong 13
JP - Giappone 12
EU - Europa 10
BR - Brasile 9
HN - Honduras 8
AT - Austria 7
ID - Indonesia 7
CH - Svizzera 5
GR - Grecia 5
HU - Ungheria 4
MD - Moldavia 4
TW - Taiwan 4
UZ - Uzbekistan 4
NG - Nigeria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 8.026
Salva come PNG Salva come JPEG
Città #
Fairfield 517
Chandler 444
Ashburn 440
Woodbridge 307
Ann Arbor 292
Wilmington 256
Houston 234
Seattle 229
Dublin 225
Cambridge 176
Medford 142
Palermo 137
Des Moines 109
Nanjing 108
Princeton 88
Singapore 84
Jacksonville 80
Boardman 70
Brussels 68
New York 58
Milan 56
Altamura 50
Seoul 48
Tulsa 41
Lawrence 40
Shenyang 40
Beijing 39
Dearborn 39
San Diego 37
Changsha 34
Venice 32
Jinan 31
Nanchang 29
Hebei 28
Santa Clara 28
Jiaxing 25
Rome 24
Verona 23
Abidjan 22
Tianjin 21
Tehran 20
Zhengzhou 20
Saint Petersburg 17
Seongnam 16
Brno 14
London 14
Naples 14
Ningbo 14
Washington 14
Falls Church 13
Helsinki 13
Kumar 13
Los Angeles 13
Ludwigshafen am Rhein 13
Toronto 13
Dallas 12
Haikou 12
Norwalk 12
Redwood City 12
Hangzhou 11
Kraków 11
Phoenix 11
Guangzhou 10
Munich 10
Taizhou 10
Auburn Hills 9
Catania 9
New Delhi 9
Amsterdam 8
Düsseldorf 8
Giza 8
Tabriz 8
Torino 8
Bologna 7
Kunming 7
Liverpool 7
Madrid 7
Napoli 7
San Paolo di Civitate 7
Tegucigalpa 7
Bremen 6
Buffalo 6
Cagliari 6
Hong Kong 6
Lanzhou 6
Pittsburgh 6
San Genesio Ed Uniti 6
Springfield 6
Taiyuan 6
Alcamo 5
Bandung 5
Caserta 5
Florence 5
Ixelles-Elsene 5
Melbourne 5
Ribeirão Prêto 5
San Mateo 5
Sydney 5
Trento 5
Ankara 4
Totale 5.307
Salva come PNG Salva come JPEG
Nome #
Emotion recognition from facial expressions: a normative study of the Ekman 60-Faces Test in the Italian population. 305
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 269
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 191
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 183
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 181
The Ekman 60-faces test: an italiana normative study 171
Sleep quality in caregivers of patients with Alzheimer’s disease and Parkinson’s disease and its relationship to quality of life 170
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 170
Klotho and vitamin D in multiple sclerosis: an Italian study 158
Anodal transcranial direct current stimulation over the right hemisphere improves auditory comprehension in a case of dementia 157
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 154
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 151
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study 140
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 138
A population-based survey of cognitive performance in a Sicilian elderly community. 136
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 136
REM sleep behavior disorder in a patient with frontotemporal dementia 134
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 134
Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients 133
Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 131
Social cognition dysfunctions in patients with epilepsy: Evidence from patients with temporal lobe and idiopathic generalized epilepsies. 130
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 128
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 120
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 119
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 116
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 114
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 106
Frontal dementia related to thalamic stroke: a case report. 106
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). 99
ELECTROCARDIOGRAPHIC FINDINGS IN PATIENTS WITH DEMENTIA. 97
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 95
In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms 94
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 93
Rey-Osterrieth Complex figure performance in patients with degenerative dementia using Boston Qualitative Scoring System 90
Reversible Pisa Syndrome in a patient with Parkinson's Disease on rasagiline therapy 89
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 86
Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with natalizumab therapy 86
Purine metabolism and Multiple Sclerosis: different pattern according to different disease stage and different clinical form. 86
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre 85
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 84
Frequency and clinical features of progranulin mutation carriers in a series of patients affected by frontotemporal lobar de generation: report of a novel mutation 83
Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients 83
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study 81
Thalamic stroke mimicking frontotemporal dementia: a case report 80
PRIMARY PROGRESSIVE CROSSED APHASIA IN A DEXTRAL WOMAN 79
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 79
Frequency of Mitoxantrone related heart involvement in patients affected by Multiple Sclerosis 76
EXTRACELLULAR VESICLES IN CEREBROSPINAL FLUID AS MARKERS OF CNS INFLAMMATION 75
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 74
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients 72
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 72
Quetiapine dose-sparing effect with addiction of memantine: two cases report of Lewy Body disease and dementia associated with Parkinson’s disease 71
Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine 71
INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS 70
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 70
PREGNANCIES MODIFY RELAPSES AND PROGRESSION IN MULTIPLE SCLEROSIS 70
Heart involvement in patients treated with mitoxantrone for multiple sclerosis 68
Chronic acquired hepatocerebral degeneration or Parkinson Disease? A case report 67
Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 65
Clinical and instrumental predictors of efficacy of Natalizumab therapy in multiple sclerosis patients: a retrospective study from a single centre 64
Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation 61
Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease 61
Emotion recognition in temporal lobe epilepsy and idiopathic generalized epilepsy 60
Approccio multidimensionale ai disturbi non motori della Malattia di Parkinson 59
Identification of three novel progranulin mutations in a series of patients affected by sporadic and familial frontotemporal lobar de generation. Platform Presentation 58
Tumor diagnosis preceding Alzheimer’s disease: a case-control study 58
Back to the life: a case of tretable dementia 55
Natalizumab therapy of relapsing-remitting multiple sclerosis: an evaluation of the safety profile and a comparison of efficacy with interferon beta therapy 55
Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life 54
Urinary dysfunction in Parkinson’s disease patients 53
RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE 52
Multiple reversibile MR signals in course of Epstein-Barr virus encephalitis 51
COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE 51
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 49
Clinical Features and disease outcome in pt with pediatric and young adult onset multiple sclerosis 49
Primary Progressive and progressive relapsing multiple sclerosis show different clinical and instrumental findings and disability progression? A comparison study on a Sicilian database 49
Primary progressive crossed aphasia in dextrals: report of three cases 48
Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease 47
Psychosis as adverse effect of cholinesterase inhibitors: two case reports of probable Alzheimer disease in treatment with galantamine 46
Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study 46
null 44
EMpathy ability and emotion recognition in temporal lobe epilepsy and idhiopathic generalizede epileps 44
Computer-assisted cognitive remediation for Parkinson’s disease 43
Reduced striatal dopamine transporter binding in posterior cortical atrophy 39
Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study 38
null 38
null 37
LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 35
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP 31
TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP 26
Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP). 23
Lifestyle factors and multiple sclerosis: a case control study 21
Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form 19
null 3
Totale 8.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.294 0 0 51 130 137 181 142 118 121 67 201 146
2020/20211.120 125 150 42 142 70 40 88 74 136 85 56 112
2021/2022963 49 205 40 47 31 43 31 64 105 110 45 193
2022/20231.600 149 184 51 154 278 257 97 129 181 18 84 18
2023/2024828 38 122 40 82 78 143 44 63 17 46 27 128
2024/2025244 63 97 84 0 0 0 0 0 0 0 0 0
Totale 8.338